The jointed efforts of several laboratories have led to the discovery of a plethora of classes of compounds with potential anti-flaviviridae activity, which will eventually display anti-HCV activity. In the panorama in which very few molecules are expected to reach the clinical trials in the next 10 years, we believe that our results could positively contribute to the development of new active substances against these life-threatening viruses.

Three- dimensional pharmacophore modeling of hindered nucleoside analogs (HNAs) as inhibitors of the hepatitic C virus NS5B polymerase

ANGUSTI, Angela;CILIBERTI, Nunzia;MANFREDINI, Stefano;
2005

Abstract

The jointed efforts of several laboratories have led to the discovery of a plethora of classes of compounds with potential anti-flaviviridae activity, which will eventually display anti-HCV activity. In the panorama in which very few molecules are expected to reach the clinical trials in the next 10 years, we believe that our results could positively contribute to the development of new active substances against these life-threatening viruses.
2005
M., Ferrone; S., Pricl; M., Fermeglia; Paneni, M. S.; Angusti, Angela; Ciliberti, Nunzia; R., Loddo; P., LA COLLA; M., Loriga; Manfredini, Stefano; M....espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/519635
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact